Tokyo, Japan

Shinwa Kurihara

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinwa Kurihara. Retrieved from https://idiyas.com/inventor/shinwa-kurihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinwa Kurihara

Introduction

Shinwa Kurihara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new therapeutic compounds. His work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of Kurihara's most recent patents is for a compound named Leustroducsin H. This compound, along with its pharmaceutically acceptable salts, is prepared through the hydrolysis of naturally occurring Leustroducsins. Leustroducsin H is particularly noteworthy for its application in the treatment or prophylaxis of thrombocytopenia. This innovative approach showcases Kurihara's commitment to advancing medical science.

Career Highlights

Shinwa Kurihara is associated with Sankyo Company, Limited, where he continues to work on groundbreaking pharmaceutical innovations. His career is marked by a dedication to research and development, contributing to the advancement of therapeutic options available in the market.

Collaborations

Throughout his career, Kurihara has collaborated with esteemed colleagues such as Yukio Sugimura and Tomoyuki Shibata. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective medical solutions.

Conclusion

Shinwa Kurihara's contributions to the field of pharmaceuticals, particularly through his patent for Leustroducsin H, highlight his role as an influential inventor. His work not only reflects his expertise but also his commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…